Similar articles for PMID: 27795359

Year	Number of Results
1854	2
1893	2
1935	1
1946	1
1947	1
1948	2
1954	1
1961	1
1970	1
1971	3
1972	1
1974	2
1975	5
1976	4
1977	6
1978	4
1979	5
1980	1
1981	3
1982	4
1983	3
1984	4
1985	3
1986	3
1987	3
1988	5
1989	2
1991	2
1992	2
1993	2
1994	1
1995	1
1997	2
1998	1
1999	1
2000	2
2001	3
2002	1
2003	3
2004	1
2005	1
2006	2
2007	1
2008	3
2009	3
2010	4
2011	4
2012	4
2013	4
2014	3
2015	6
2016	3
2017	8
2018	8
2019	4
2020	6
2021	4
2024	0

1

Immunity Provided by an Outer Membrane Vesicle Cholera Vaccine Is Due to O-Antigen-Specific Antibodies Inhibiting Bacterial Motility.

Wang Z, Lazinski DW, Camilli A. Wang Z, et al. Infect Immun. 2016 Dec 29;85(1):e00626-16. doi: 10.1128/IAI.00626-16. Print 2017 Jan. Infect Immun. 2016. PMID: 27795359 Free PMC article.

2

Lipopolysaccharide modifications of a cholera vaccine candidate based on outer membrane vesicles reduce endotoxicity and reveal the major protective antigen.

Leitner DR, Feichter S, Schild-Prüfert K, Rechberger GN, Reidl J, Schild S. Leitner DR, et al. Infect Immun. 2013 Jul;81(7):2379-93. doi: 10.1128/IAI.01382-12. Epub 2013 Apr 29. Infect Immun. 2013. PMID: 23630951 Free PMC article.

3

Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility.

Bishop AL, Schild S, Patimalla B, Klein B, Camilli A. Bishop AL, et al. Infect Immun. 2010 Oct;78(10):4402-20. doi: 10.1128/IAI.00398-10. Epub 2010 Aug 2. Infect Immun. 2010. PMID: 20679439 Free PMC article.

4

Immunization of mice with vibrio cholerae outer-membrane vesicles protects against hyperinfectious challenge and blocks transmission.

Bishop AL, Tarique AA, Patimalla B, Calderwood SB, Qadri F, Camilli A. Bishop AL, et al. J Infect Dis. 2012 Feb 1;205(3):412-21. doi: 10.1093/infdis/jir756. Epub 2011 Dec 5. J Infect Dis. 2012. PMID: 22147790 Free PMC article.

5

Humans Surviving Cholera Develop Antibodies against Vibrio cholerae O-Specific Polysaccharide That Inhibit Pathogen Motility.

Charles RC, Kelly M, Tam JM, Akter A, Hossain M, Islam K, Biswas R, Kamruzzaman M, Chowdhury F, Khan AI, Leung DT, Weil A, LaRocque RC, Bhuiyan TR, Rahman A, Mayo-Smith LM, Becker RL, Vyas JM, Faherty CS, Nickerson KP, Giffen S, Ritter AS, Waldor MK, Xu P, Kováč P, Calderwood SB, Kauffman RC, Wrammert J, Qadri F, Harris JB, Ryan ET. Charles RC, et al. mBio. 2020 Nov 17;11(6):e02847-20. doi: 10.1128/mBio.02847-20. mBio. 2020. PMID: 33203761 Free PMC article.

6

Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera.

Schild S, Nelson EJ, Bishop AL, Camilli A. Schild S, et al. Infect Immun. 2009 Jan;77(1):472-84. doi: 10.1128/IAI.01139-08. Epub 2008 Nov 10. Infect Immun. 2009. PMID: 19001078 Free PMC article.

7

Assessment of Mouse Ileal loop Protection against Clinically Isolated Vibrio cholerae Outer Membrane Vesicles as a Vaccine Candidate.

Sedaghat M, Siadat SD, Shahcheraghi F, Mirabzadeh Ardakani E, Keramati M, Vaziri F, Nojoumi SA. Sedaghat M, et al. Arch Razi Inst. 2021 Jan;75(4):451-461. doi: 10.22092/ari.2019.126909.1365. Epub 2021 Jan 1. Arch Razi Inst. 2021. PMID: 33403840 Free PMC article.

8

Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphology.

Levinson KJ, De Jesus M, Mantis NJ. Levinson KJ, et al. Infect Immun. 2015 Apr;83(4):1674-83. doi: 10.1128/IAI.02856-14. Epub 2015 Feb 9. Infect Immun. 2015. PMID: 25667263 Free PMC article.

9

Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.

Liao J, Gibson JA, Pickering BS, Watnick PI. Liao J, et al. mSphere. 2018 Jun 6;3(3):e00245-18. doi: 10.1128/mSphere.00245-18. Print 2018 Jun 27. mSphere. 2018. PMID: 29875145 Free PMC article.

10

Retinoic acid pre-treatment down regulates V. cholerae outer membrane vesicles induced acute inflammation and enhances mucosal immunity.

Sinha R, Howlader DR, Ta A, Mitra S, Das S, Koley H. Sinha R, et al. Vaccine. 2017 Jun 16;35(28):3534-3547. doi: 10.1016/j.vaccine.2017.05.036. Epub 2017 May 22. Vaccine. 2017. PMID: 28545924

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

155 results

Results by year